ANL Stock Analysis: Buy, Sell, or Hold?
$12.17
-1.08 (-8.15%)
▼
5d:
-23.75%
30d:
+88.39%
90d:
+238.06%
WAIT
LOW Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: Apr 29, 2026
0d
Get Alerted When ANL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ANL is down 23.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ANL is down 23.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ANL is currently trading at $12.17, which is considered fair relative to its 30-day fair value range of $7.56 to $14.65.
Technical Outlook: Technically, ANL is in a strong uptrend. Immediate support is located at $7.20, while resistance sits at $17.25. Short-term momentum is weak, with the stock down 8.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.67 (+143.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ANL is in a strong uptrend. Immediate support is located at $7.20, while resistance sits at $17.25. Short-term momentum is weak, with the stock down 8.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.67 (+143.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$7.56 -
$14.65
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.2%)
- BULLISH: Trading 143.8% below Wall St target ($29.67)
- WARNING: Recommendation downgraded due to -23.7% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$7.56 -
$14.65
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$7.20
Resistance Level
$17.25
Current Trend
Strong Uptrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-35.28
Wall Street Target
$29.67
(+143.8%)
Revenue Growth (YoY)
178.1%
Share & Embed Analysis
Last updated: April 29, 2026 2:54 AM ET
Data refreshes hourly during market hours. Next update: 3:54 AM
Data refreshes hourly during market hours. Next update: 3:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANL showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 59 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$878 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |